US67066Y1055

We assign a fundamental rating of **2** out of 10 to **NAC**. **NAC** was compared to 0 industry peers in the **Unkown** industry. **NAC** may be in some trouble as it scores bad on both profitability and health. **NAC** has a expensive valuation and it also scores bad on growth.

In multiple years **NAC** reported negative net income over the last 5 years.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -1.14% | ||

ROE | -1.95% | ||

ROIC | 0.34% |

ROA(3y)-3.61%

ROA(5y)0.06%

ROE(3y)-6.03%

ROE(5y)-0.15%

ROIC(3y)N/A

ROIC(5y)N/A

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 16.44% | ||

PM (TTM) | N/A | ||

GM | 17.16% |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

Compared to 1 year ago, **NAC** has about the same amount of shares outstanding.

The number of shares outstanding for **NAC** has been reduced compared to 5 years ago.

Compared to 1 year ago, **NAC** has a worse debt to assets ratio.

Based on the Altman-Z score of **0.79**, we must say that **NAC** is in the distress zone and has some risk of bankruptcy.

The Debt to FCF ratio of **NAC** is **12.37**, which is on the high side as it means it would take **NAC**, **12.37** years of fcf income to pay off all of its debts.

A Debt/Equity ratio of **0.70** indicates that **NAC** is somewhat dependend on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.7 | ||

Debt/FCF | 12.37 | ||

Altman-Z | 0.79 |

ROIC/WACCN/A

WACCN/A

A Current Ratio of **2.20** indicates that **NAC** has no problem at all paying its short term obligations.

A Quick Ratio of **2.20** indicates that **NAC** has no problem at all paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.2 | ||

Quick Ratio | 2.2 |

The **Earnings Per Share** has grown by an impressive **90.73%** over the past year.

Measured over the past years, **NAC** shows a very negative growth in **Revenue**. The Revenue has been decreasing by **-35.14%** on average per year.

EPS 1Y (TTM)90.73%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100.58%

Revenue 1Y (TTM)26.43%

Revenue growth 3Y-50.39%

Revenue growth 5Y-35.14%

Sales Q2Q%20313.33%

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 17.07 | ||

EV/EBITDA | N/A |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

Compared to an average S&P500 **Dividend Yield** of **2.26**, **NAC** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 5.16% |

The dividend of **NAC** decreases each year by **-5.57%**.

Dividend Growth(5Y)-5.57%

Div Incr Years1

Div Non Decr Years1

The earnings of **NAC** are negative and hence is the payout ratio. **NAC** will probably not be able to sustain this dividend level.

DP-203.46%

EPS Next 2YN/A

EPS Next 3YN/A

**NUVEEN CA QLTY MUNI INC**

NYSE:NAC (9/16/2024, 8:04:00 PM)

**11.89**

**-0.02 (-0.17%) **

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap1.72B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 5.16% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -1.14% | ||

ROE | -1.95% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 16.44% | ||

PM (TTM) | N/A | ||

GM | 17.16% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.03

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.7 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.2 | ||

Quick Ratio | 2.2 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)90.73%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next YN/A

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)26.43%

Revenue growth 3Y-50.39%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y